thymopentin has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, GL; Guo, SL; Han, LN; Li, TL; Ma, JL; Zhang, YJ | 1 |
| Fangfang, C; Xiaojing, C; Yanfang, L; Yanqing, G | 1 |
2 trial(s) available for thymopentin and Cardiac Failure
| Article | Year |
|---|---|
Effect of immune modulation therapy on cardiac function and T-bet/GATA-3 gene expression in aging male patients with chronic cardiac insufficiency.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; C-Reactive Protein; Chronic Disease; Echocardiography; Flow Cytometry; GATA3 Transcription Factor; Gene Expression; Heart Failure; Humans; Interferon-gamma; Interleukin-4; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Box Domain Proteins; Th1 Cells; Th2 Cells; Thymopentin; Treatment Outcome | 2013 |
Thymopentin improves cardiac function in older patients with chronic heart failure.
Topics: Adjuvants, Immunologic; Aged; Aging; C-Reactive Protein; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Surveys and Questionnaires; Thymopentin; Ventricular Function, Left | 2017 |